Ontario-based licensed producer Tilray has completed its first sale of medical cannabis products in Malta.
In 2020, about 40,000 medical patients were affected when a historic drought left the country short on supply.
“So much for [Malta being] the medical hub of Europe,” Andrew Bonello, president of the non-profit advocacy group, Releaf Malta, told Lovin Malta.
“One of the medicinal cannabis brands, Pedanios, has been out of stock for around a month and Bedrocan, the only other alternative, has been out of stock for two or three weeks,” Bonello reported at the time.
The drought prompted calls for reforming the country’s system of securing and distributing the plant.
“Many people just want to be able to grow their own cannabis as they just cannot afford the exorbitant prices,” Bonello said. “How can a cancer patient afford €960 (about $1,400) a month when they
Read full article on The Growth Op
